Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Enhanced neutralization potency of an identical HIV neutralizing antibody expressed as different isotypes is achieved through genetically distinct mechanisms
Thandeka Moyo-Gwete, Cathrine Scheepers, Zanele Makhado, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 10

Showing 10 citing articles:

Antiviral neutralizing antibodies: from in vitro to in vivo activity
Dennis R. Burton
Nature reviews. Immunology (2023) Vol. 23, Iss. 11, pp. 720-734
Open Access | Times Cited: 61
IgA class switching enhances neutralizing potency against SARS-CoV-2 by increased antibody hinge flexibility
Mengxin Xu, Zhaoyong Zhang, Yuzhu Sun, et al.
Antiviral Research (2025) Vol. 235, pp. 106082-106082
Closed Access
Broadly neutralizing antibodies for HIV prevention: a comprehensive review and future perspectives
Sharana Mahomed
Clinical Microbiology Reviews (2024) Vol. 37, Iss. 2
Closed Access | Times Cited: 4
Antibodies from dengue patients with prior exposure to Japanese encephalitis virus are broadly neutralizing against Zika virus
Gielenny M. Salem, Jedhan Ucat Galula, Shang‐Rung Wu, et al.
Communications Biology (2024) Vol. 7, Iss. 1
Open Access | Times Cited: 2
Polyfunctional antibodies: a path towards precision vaccines for vulnerable populations
Ruth A Purcell, Robert M. Theisen, Kelly B. Arnold, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 7
Antibody class-switching as a strategy to improve HIV-1 neutralization
Cathrine Scheepers, Simone I. Richardson, Thandeka Moyo-Gwete, et al.
Trends in Molecular Medicine (2022) Vol. 28, Iss. 11, pp. 979-988
Open Access | Times Cited: 9
Isolation and characterization of IgG3 glycan-targeting antibodies with exceptional cross-reactivity for diverse viral families
Matthew J. Vukovich, Andrea R. Shiakolas, Jared Lindenberger, et al.
PLoS Pathogens (2024) Vol. 20, Iss. 9, pp. e1012499-e1012499
Open Access | Times Cited: 1
Functional comparison of Fc-engineering strategies to improve anti-HIV-1 antibody effector functions
Angela I. Schriek, David Falck, Manfred Wuhrer, et al.
Antiviral Research (2024), pp. 106015-106015
Open Access | Times Cited: 1
SARS‐CoV‐2 neutralising antibody therapies: Recent advances and future challenges
Mingtao Liu, Zhiman Liang, Zhangkai J. Cheng, et al.
Reviews in Medical Virology (2023) Vol. 33, Iss. 5
Closed Access | Times Cited: 4
Induction of Tier 2 HIV-Neutralizing IgA Antibodies in Rhesus Macaques Vaccinated with BG505.664 SOSIP
Justin C. Smith, Prabhu S. Arunachalam, Traci Legere, et al.
Vaccines (2024) Vol. 12, Iss. 12, pp. 1386-1386
Open Access
Page 1

Scroll to top